ORPHA:96176
Ring chromosome 13 syndrome
Also known as: Ring 13 · Ring chromosome 13
Query health: suspect — Only one of 2 strategies returned hits (phrase).
Publications
1,366
Trials
0
Interventional, condition-specific
Researchers
1,192
Distinct authors in sample
Gene link
—
Readiness
2/6
Stages with a signal
Clinical definition (Orphanet)
A rare chromosomal anomaly of chromosome 13 characterized by a widely variable (ranging from mild to severe) principally characterized by intrauterine growth retardation, , short stature, moderate to severe intellectual deficit, microcephaly, facial dysmorphism (i.e. upslanting palpebral fissures, hypertelorism, abnormal ears, broad nasal bridge, high arched palate, micrognathia, small mouth, and thin lips), hands and feet anomalies, and genital abnormalities. Additional features reported include behavioral problems, hearing and speech disorders, heart defects, cerebral malformations, and anal atresia.
How rare: How common this is has not been clearly measured.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0019907
- MeSH:C538303
- UMLS:C2931808
Additional Mondo synonyms (1)
Ring chromosome type 13
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
2/6 stages with a signal
Research-stage checklist from open sources (GenCC, literature, Monarch when enriched, ClinicalTrials.gov). Not a prognosis or care recommendation.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
1,366 matched papers (648 in last 10 years) Source
- Phenotype characterisedPresent
42 HPO annotations (e.g. Severe intellectual disability; Micropenis; Anteverted nares) Source
- Animal modelNot found
No Alliance genotype “model of” associations via Monarch for these Mondo IDs
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialNot found
No matched interventional trial under our ClinicalTrials.gov rules
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
42
Associated phenotypes · MONDO:0019907
- Severe intellectual disability
- Micropenis
- Anteverted nares
- Primary hypothyroidism
- Skeletal dysplasia
Showing 5 of 42 — open Monarch for the full list.
Animal models (Monarch / Alliance)
None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
No drugs or clinical candidates returned for this Mondo ID on Open Targets.
CTD chemicals (MyDisease.info)
No CTD chemical associations returned for this Mondo ID.
Literature
Is anyone studying this?
1,366
1,366 papers have been published on this condition. That is a real research literature — still far smaller than common diseases (breast cancer: over 700,000 papers). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
1,366 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
648 in the last 10 years · low confidence
Phrase hits: 1,366 · MeSH hits: 0
Who's working on it?
1,192
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.
- 01VAN Loon LJC11 papers · 2025
Department of Human Biology, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre+, P.O. Box 616, 6200 MD, Maastricht, The Netherlands. L.vanLoon@maastrichtuniversity.nl.
Papers in Europe PMC - 02Hendriks FK7 papers · 2025
Department of Human Biology, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre+, P.O. Box 616, 6200 MD, Maastricht, The Netherlands.
Papers in Europe PMC - 03Senden JM7 papers · 2025
Department of Human Biology, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre+, P.O. Box 616, 6200 MD, Maastricht, The Netherlands.
Papers in Europe PMC - 04Goessens JPB6 papers · 2025
Department of Human Biology, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre+, P.O. Box 616, 6200 MD, Maastricht, The Netherlands.
Papers in Europe PMC - 05Snijders T6 papers · 2025
Department of Human Biology, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre+, Maastricht, THE NETHERLANDS.
Papers in Europe PMC - 06VAN Kranenburg JMX6 papers · 2025
Department of Human Biology, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre+, P.O. Box 616, 6200 MD, Maastricht, The Netherlands.
Papers in Europe PMC - 07Chen CP5 papers · 2023
Department of Obstetrics and Gynecology, Mackay Memorial Hospital, Taipei, Taiwan; Department of Medical Research, Mackay Memorial Hospital, Taipei, Taiwan; Department of Biotechnology, Asia University, Taichung, Taiwan; School of Chinese Medicine, College of Chinese Medicine, China Medical University, Taichung, Taiwan; Institute of Clinical and Community Health Nursing, National Yang-Ming University, Taipei, Taiwan; Department of Obstetrics and Gynecology, School of Medicine, National Yang-Ming University, Taipei, Taiwan. Electronic address: cpc_mmh@yahoo.com.
Papers in Europe PMC - 08Verdijk LB5 papers · 2025
Department of Human Biology, NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University Medical Centre+, P.O. Box 616, 6200 MD, Maastricht, The Netherlands.
Papers in Europe PMC - 09Smeets JSJ4 papers · 2024
NUTRIM School of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, The Netherlands.
Papers in Europe PMC - 10Aussieker T3 papers · 2025
Department of Human Biology, School of Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University Medical Centre , Maastricht, THE NETHERLANDS.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
0
interventional trials for this specific condition
No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present).
Data as of 11 September 2026 · last trial check 11 September 2026
No matched interventional trials. This is true for 77.2% of diseases in the trials denominator (5501 of 7126). Here are the researchers publishing on it.
low confidence · 38.6th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
See who's working on it — people publishing on this disease are often the practical next contact when no trial is listed.
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 40 · after dedupe 40 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 40 · dropped 0 · fetched 2026-07-30
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Uncertain / not reviewed (40)
- isrctn·ISRCTN82481391·No longer recruiting·A study in healthy participants to assess how the cannabidiol is absorbed into the blood, after inhalation via a new device that heats without burning the hemp
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN11399176·Recruiting·Safer labour induction with the EBLIA balloon
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN22165252·No longer recruiting·TinnSpire: Personalised vagus nerve & sound stimulation for the treatment of tinnitus
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN18283468·No longer recruiting·A clinical trial to learn more about the absorption of radiolabeled drug LXE408, how the body breaks it down, and how quickly the body gets rid of it in healthy men
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN33793580·Recruiting·18F-LW223: A new tool for detecting inflammation in the body
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN16645843·Recruiting·Efficacy of CliMACT, a digital training for mental health promotion in youth with climate change-related distress
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN17870921·No longer recruiting·Behavioural change for cancer prevention: A pilot study protocol of a digital intervention
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN12166286·No longer recruiting·A study in healthy adults to compare the bioavailability of EPA + DHA from two microalgal sources to one fish source and placebo
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN15148230·No longer recruiting·A comparative bioavailability study of ethinyl estradiol/etonogestrel vaginal ring in healthy female subjects
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN12852894·No longer recruiting·A study comparing a new lidocaine plaster (IBSA Lidocaine 5% medicated plaster) to the marketed Versatis® plaster in healthy volunteers – looking at how well the new plaster delivers the medicine into the body (bioequivalence), how well it sticks to the skin (adhesion), and how the skin reacts (tolerability)
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN10774395·Recruiting·Silicone compared to polyvinyl chloride ring pessary in the treatment of vaginal prolapse
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN14632228·Recruiting·Research study for people who have cerebral small vessel disease (cSVD, damaged small blood vessels in the brain) and a stroke, which may lead to impaired memory and thinking and then dementia
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN64027792·Recruiting·Measuring the change in genetic markers of antibiotic resistance carried in the nasopharynx of children with pneumonia in Blantyre, Malawi, and assessing whether this is associated with poor health outcomes
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN11396451·Enrolling by Invitation·Dietary approaches to the management of polycystic ovary syndrome trial
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN15460184·No longer recruiting·Application of local anaesthetic cream at ring pessary change in vaginal prolapse
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN13394796·No longer recruiting·A study to investigate the safety and efficacy of Maizinol™ on sleep quality in a healthy population with difficulty falling asleep or staying asleep
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN17198496·No longer recruiting·Effects of a liquid blend containing kava and kratom in healthy adults
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN10994968·No longer recruiting·Using width or length assessed by digital examination for selecting the first ring size at ring pessary fitting for the management of vaginal prolapse
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN29801527·No longer recruiting·A study to characterize nicotine delivery of the JUUL2 electronic nicotine delivery system in adults as compared to a commercially available e-cigarette and combustible cigarette
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN65886044·No longer recruiting·Contact lens performance comparison
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN15140257·Stopped·Effect of Icosapent ethyl on inflammation in the vessel wall assessed by the Fat Attenuation Index Score (IRIS-FAI)
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN34837836·No longer recruiting·A study to characterize nicotine delivery of the JUUL2 electronic nicotine delivery system as compared to a commercially available e-cigarette and combustible cigarette
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN16176441·No longer recruiting·A clinical study to evaluate the contents of exhaled breath after use of the JUUL2 electronic nicotine delivery system and conventional cigarettes
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN14728094·No longer recruiting·Does magnesium improve adults' sleep, mood, and anxiety?
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN67032901·No longer recruiting·The impact of the circadian clock on retinal function
skipped — LLM skipped (--skip-llm)
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Ring chromosome 13 syndrome — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Ring chromosome 13 syndrome" OR "Ring 13" OR "Ring chromosome 13" OR "Ring chromosome type 13"
MeSH descriptor terms unioned into the query: Chromosome 13 ring
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Ring chromosome 13 syndrome" OR "Ring 13" OR "Ring chromosome 13" OR "Ring chromosome type 13" OR "Chromosome 13 ring"
Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: suspect — strategies attempted: phrase, mesh; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
- Publication count (1366) is extremely high with unknown/missing prevalence — treat as possible over-matching, not proven research intensity
Ingested 2026-07-27T04:57:07.906Z
